Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant SOX vs SOX plus CRT in proximal gastric adenocarcinoma
NCT03973008Phase 3Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Mar 2019
- Primary completion
- Feb 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, tegafur + gimeracil + oteracil potassium in gastric adenocarcinoma, sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
oxaliplatintegafur + gimeracil + oteracil potassium
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT03973008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03973008.